Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Rangering i aksjer #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aksjekurs
$44.60
Markedsverdi
$108.62B
Endring (1 dag)
-1.63%
Endring (1 år)
-21.62%
Land
FR
Handel Sanofi (SNY)

Kategori

EPS for Sanofi (SNY)
EPS per December 2025 TTM: $2.38
Ifølge de siste økonomiske rapportene og aksjekursen til Sanofi er selskapets nåværende EPS (TTM) $2.38. Ved slutten av 2024 hadde selskapet en EPS på $2.28, en nedgang sammenlignet med EPS-en i 2023 som var $2.38.
EPS-historikk for Sanofi fra 2000 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $2.38 0.07%
2025 $2.38 4.52%
2024 $2.28 -4.12%
2023 $2.38 -30.54%
2022 $3.42 20.85%
2021 $2.83 -52.65%
2020 $5.98 367.50%
2019 $1.28 -35.66%
2018 $1.99 10.45%
2017 $1.80 -6.52%
2016 $1.93 8.13%
2015 $1.78 -11.87%
2014 $2.02 4.21%
2013 $1.94 -20.54%
2012 $2.44 -12.32%
2011 $2.78 -0.87%
2010 $2.81 -3.06%
2009 $2.90 -24.43%
2008 $3.83 33.77%
2007 $2.87 46.14%
2006 $1.96 97.53%
2005 $0.99 -33.46%
2004 $1.49 -19.97%
2003 $1.86 46.78%
2002 $1.27 31.05%
2001 $0.97 52.20%
2000 $0.64 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$23.00 865.70%
US
$13.20 454.23%
GB
$11.10 366.05%
US
$2.37 -0.49%
US
$7.20 202.31%
CH